Stryker's Wingspan Stent May Raise Stroke Risk, FDA Says
Medical technology company Stryker Corp.'s Wingspan stent used to prevent strokes may come with increased stroke risks that outweigh their potential benefits, the U.S. Food and Drug Administration said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article